Lamisil AT Continuous Spray

Name: Lamisil AT Continuous Spray

Active ingredient

Terbinafine hydrochloride

Do Not Use

  • on nails or scalp
  • in or near the mouth or the eyes
  • for vaginal yeast infections

Directions

  • adults and children 12 years and over
    • wash the affected area with soap and water and dry completely before applying
    • to open remove clear cap.
    • hold can 4" to 6" from skin.  Press and hold to spray a thin layer over affected area
    • spray affected area once a day (morning or night) for 1 week or as directed by a doctor
    • release to stop spray
    • wipe excess from spray opening after each use
    • return cap to can
    • wash hands after each use
  • children under 12 years: ask a doctor

Other information

store at 8° - 25° C (46° - 77° F)

Principal Display

LAMISIL  AT CONTINUOUS SPRAY
terbinafine hydrochloride liquid
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:0067-6293
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
TERBINAFINE HYDROCHLORIDE (TERBINAFINE) TERBINAFINE HYDROCHLORIDE 1.25 mL  in 125 mL
Inactive Ingredients
Ingredient Name Strength
ALCOHOL  
POLYOXYL 20 CETOSTEARYL ETHER  
PROPYLENE GLYCOL  
WATER  
Packaging
# Item Code Package Description
1 NDC:0067-6293-83 125 mL in 1 BOTTLE, SPRAY
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021124 07/23/2009
Labeler - Novartis Consumer Health, Inc. (879821635)
Revised: 01/2010   Novartis Consumer Health, Inc.

For Healthcare Professionals

Applies to terbinafine topical: topical cream, topical gel, topical solution, topical spray

Dermatologic

Dermatologic side effects have included burning or irritation (1.3%), itching (1.1%), skin exfoliation (1%), and erythematous rash (0.9%).[Ref]

General

Therapy was discontinued in clinical trials by 0.2% of patients treated with terbinafine solution and 0.6% of patients treated with placebo.[Ref]

Some side effects of Lamisil AT Spray may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Share
(web3)